Does ILOPROST Cause Off label use? 176 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Off label use have been filed in association with ILOPROST (AURLUMYN). This represents 3.6% of all adverse event reports for ILOPROST.
176
Reports of Off label use with ILOPROST
3.6%
of all ILOPROST reports
54
Deaths
74
Hospitalizations
How Dangerous Is Off label use From ILOPROST?
Of the 176 reports, 54 (30.7%) resulted in death, 74 (42.0%) required hospitalization, and 12 (6.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ILOPROST Alternatives Have Lower Off label use Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT